59 studies found for:    Open Studies | "Niacin"
Show Display Options
Rank Status Study
21 Recruiting The Topical Niacin Skin Flush Test in First Episode Psychosis
Conditions: Psychotic Disorders;   Schizophrenia
Intervention: Other: skin test
22 Recruiting Gulf War Illness: Evaluation of an Innovative Detoxification Program
Condition: Persian Gulf War Syndrome in Veteran
Intervention: Other: Hubbard detoxification program
23 Unknown  Assessing the Effects of a Topically Applied Cream to Clitoral Blood Flow
Condition: Female Sexual Dysfunction
Interventions: Drug: arginine 20%, nicotinamide .01%, niacin.1%, in LipodermPG 50%;   Drug: Topical study cream;   Drug: GRAS cream
24 Recruiting Beneficial Effects of Quercetin in Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: Quercetin
25 Recruiting Feasibility and Effectiveness of Micronutrients as Palliative Care Therapy in Patients With Congestive Heart Failure
Conditions: Congestive Heart Failure;   Ischemic Cardiomyopathy
Intervention: Drug: Micronutrients
26 Recruiting A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High Risk Patients With Hypertriglyceridemia and on Statin. The Primary Objective is to Evaluate the Effect of 4 g/Day AMR101 for Preventing the Occurrence of a First Major Cardiovascular Event.
Condition: Cardiovascular Diseases
Interventions: Drug: AMR101;   Drug: Placebo
27 Unknown  A Study on Psychopathological Progress of Early Schizophrenia-Like Disorder (SOPRES)
Condition: Schizophrenia
Intervention:
28 Unknown  Study to Evaluate the Efficacy and Tolerability of Apevinat BC Compared to Vitamin Complex
Conditions: Lack of Appetite;   Anorexia
Interventions: Drug: Apevinat BC;   Drug: Vitamin Complex
29 Recruiting Iron and Prebiotics Fortification in Kenyan Infants
Conditions: Anemia;   Iron Deficiency;   Diarrhea;   Malaria;   Respiratory Tract Infections (RTI)
Intervention: Dietary Supplement: Fortified maize porridge
30 Unknown  Prostate Cancer Prevention Trial With Quercetin and Genistein
Condition: Primary Prevention of Prostate Cancer
Interventions: Dietary Supplement: Quercetin supplement;   Dietary Supplement: Genistein supplement;   Dietary Supplement: Placebo
31 Unknown  Effect of Micronutrients and Exercise During Pregnancy on Factors Related With Non-Transmissible Chronic Diseases
Conditions: Preeclampsia;   Pregnancy;   Micronutrients;   Exercise
Interventions: Behavioral: Regular aerobic physical exercise;   Dietary Supplement: Micronutrients;   Other: Activities of daily living + placebo
32 Recruiting Sorafenib Tosylate Before and After Donor Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia
Condition: Adult Acute Myeloid Leukemia in Remission
Interventions: Procedure: Bone Marrow Transplantation;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Sorafenib Tosylate
33 Recruiting Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Adult Hepatocellular Carcinoma;   Advanced Adult Hepatocellular Carcinoma;   BCLC Stage C Adult Hepatocellular Carcinoma;   BCLC Stage D Adult Hepatocellular Carcinoma;   Localized Non-Resectable Adult Liver Carcinoma;   Recurrent Adult Liver Carcinoma
Interventions: Drug: Doxorubicin Hydrochloride;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Sorafenib Tosylate
34 Recruiting Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery
Conditions: Kidney Cancer;   Liver Cancer
Interventions: Drug: hypoxia-activated prodrug TH-302;   Drug: sorafenib tosylate;   Genetic: protein analysis;   Other: laboratory biomarker analysis
35 Recruiting Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer
Conditions: Recurrent Renal Cell Carcinoma;   Stage III Renal Cell Cancer;   Stage IV Renal Cell Cancer
Interventions: Biological: Bevacizumab;   Other: Laboratory Biomarker Analysis;   Drug: Pazopanib Hydrochloride;   Other: Pharmacological Study;   Drug: Sorafenib Tosylate;   Drug: Sunitinib Malate;   Biological: Trebananib
36 Recruiting Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Conditions: Adult Hepatocellular Carcinoma;   Adult Pleomorphic Hepatocellular Carcinoma;   Advanced Adult Hepatocellular Carcinoma;   BCLC Stage C Adult Hepatocellular Carcinoma;   BCLC Stage D Adult Hepatocellular Carcinoma;   Childhood Hepatocellular Carcinoma;   Localized Non-Resectable Adult Liver Carcinoma;   Recurrent Adult Liver Carcinoma;   Recurrent Childhood Liver Cancer;   Stage III Childhood Hepatocellular Carcinoma;   Stage IV Childhood Hepatocellular Carcinoma
Interventions: Drug: Sorafenib Tosylate;   Other: Laboratory Biomarker Analysis
37 Recruiting Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Advanced Adult Hepatocellular Carcinoma;   BCLC Stage B Adult Hepatocellular Carcinoma;   BCLC Stage C Adult Hepatocellular Carcinoma
Interventions: Dietary Supplement: Chinese herbal formulation PHY906;   Drug: sorafenib tosylate;   Other: laboratory biomarker analysis;   Other: pharmacological study
38 Unknown  Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery
Condition: Liver Cancer
Interventions: Drug: sorafenib tosylate;   Other: laboratory biomarker analysis;   Procedure: neoadjuvant therapy;   Procedure: therapeutic conventional surgery
39 Recruiting Sorafenib Tosylate, Valproic Acid, and Sildenafil Citrate in Treating Patients With Recurrent High-Grade Glioma
Conditions: Brain and Nervous System;   Glioblastoma;   Glioma
Interventions: Drug: sorafenib tosylate;   Drug: valproic acid;   Drug: sildenafil citrate
40 Recruiting Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia
Conditions: Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11;   Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11;   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1;   Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL;   Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA;   Alkylating Agent-Related Acute Myeloid Leukemia;   Recurrent Adult Acute Myeloid Leukemia;   Secondary Acute Myeloid Leukemia;   Untreated Adult Acute Myeloid Leukemia
Interventions: Drug: Bortezomib;   Drug: Sorafenib Tosylate;   Drug: Decitabine;   Other: Pharmacological Study;   Other: Laboratory Biomarker Analysis

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-59) Show next page of results    Last Page
Indicates status has not been verified in more than two years